Metraipolis › archive › dc_9cafe23029bb
Hepatobiliary adverse drug reactions during treatment with olaparib: an analysis of data from the EudraVigilance reporting system — Europe PMC PMID:41586430
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41586430
- DOI
- 10.3389/fdsfr.2025.1736759
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T23:07:02.994Z
- SHA-256 of the archived text
7f753d2de678fc5d4c8909173c7b211ed2fb6c31c3c4cece88811af56e2cb6d0- Stable URL of this page
https://metraipolis.com/documento/dc_9cafe23029bb
How to cite
Hepatobiliary adverse drug reactions during treatment with olaparib: an analysis of data from the EudraVigilance reporting system — Europe PMC PMID:41586430 — Europe PMC (en), https://europepmc.org/article/MED/41586430 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9cafe23029bb (Metraipolis archive dc_9cafe23029bb, sha256 7f753d2de678fc5d4c8909173c7b211ed2fb6c31c3c4cece88811af56e2cb6d0)
BibTeX
@misc{dc9cafe23029bb,
title = {Hepatobiliary adverse drug reactions during treatment with olaparib: an analysis of data from the EudraVigilance reporting system — Europe PMC PMID:41586430},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41586430},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9cafe23029bb; sha256 7f753d2de678fc5d4c8909173c7b211ed2fb6c31c3c4cece88811af56e2cb6d0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41586430. Agents can read the archived copy with the MCP tool read_document.